In C9ALS/FTD, molecules targeting G4C2-repeat RNA have therapeutic potential by preventing pathogenic interactions of the expanded RNA with RBPs, and/or by interfering with RAN translation. This evidence concerns the gene RAN and frontotemporal dementia.